Response and toxicity prediction by MALDI-TOF-MS serum peptide profiling in patients with non-small cell lung cancer.
Saved in:
| Title: | Response and toxicity prediction by MALDI-TOF-MS serum peptide profiling in patients with non-small cell lung cancer. |
|---|---|
| Authors: | Rovithi M; Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands., Lind JS; Department of Pulmonary Diseases, VU University Medical Center, Amsterdam, The Netherlands., Pham TV; OncoProteomics Laboratory, Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands., Voortman J; Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands., Knol JC; OncoProteomics Laboratory, Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands., Verheul HM; Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands., Smit EF; Department of Pulmonary Diseases, VU University Medical Center, Amsterdam, The Netherlands., Jimenez CR; OncoProteomics Laboratory, Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands. |
| Source: | Proteomics. Clinical applications [Proteomics Clin Appl] 2016 Jul; Vol. 10 (7), pp. 743-9. Date of Electronic Publication: 2016 May 27. |
| Publication Type: | Clinical Trial, Phase II; Journal Article |
| Journal Info: | Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 101298608 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1862-8354 (Electronic) Linking ISSN: 18628346 NLM ISO Abbreviation: Proteomics Clin Appl Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
